The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Traveler's Diarrhea Therapeutics Market Research Report 2024
Synopsis
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
The global Traveler's Diarrhea Therapeutics market was valued at US$ 785.4 million in 2023 and is anticipated to reach US$ 1276.6 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
This report aims to provide a comprehensive presentation of the global market for Traveler's Diarrhea Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traveler's Diarrhea Therapeutics.
Report Scope
The Traveler's Diarrhea Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Traveler's Diarrhea Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traveler's Diarrhea Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Traveler's Diarrhea Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
The global Traveler's Diarrhea Therapeutics market was valued at US$ 785.4 million in 2023 and is anticipated to reach US$ 1276.6 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
This report aims to provide a comprehensive presentation of the global market for Traveler's Diarrhea Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Traveler's Diarrhea Therapeutics.
Report Scope
The Traveler's Diarrhea Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Traveler's Diarrhea Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Traveler's Diarrhea Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Segment by Type
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Others
Segment by Application
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Traveler's Diarrhea Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Traveler's Diarrhea Therapeutics Market Overview
1.1 Product Overview and Scope of Traveler's Diarrhea Therapeutics
1.2 Traveler's Diarrhea Therapeutics Segment by Type
1.2.1 Global Traveler's Diarrhea Therapeutics Market Value Comparison by Type (2024-2030)
1.2.2 Immunization
1.2.3 Non-antibiotic Agents
1.2.4 Antibiotics
1.2.5 Anti-Motility Agents
1.2.6 Others
1.3 Traveler's Diarrhea Therapeutics Segment by Application
1.3.1 Global Traveler's Diarrhea Therapeutics Market Value by Application: (2024-2030)
1.3.2 Adult Traveler's Diarrhea
1.3.3 Children Traveler's Diarrhea
1.4 Global Traveler's Diarrhea Therapeutics Market Size Estimates and Forecasts
1.4.1 Global Traveler's Diarrhea Therapeutics Revenue 2019-2030
1.4.2 Global Traveler's Diarrhea Therapeutics Sales 2019-2030
1.4.3 Global Traveler's Diarrhea Therapeutics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Traveler's Diarrhea Therapeutics Market Competition by Manufacturers
2.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Traveler's Diarrhea Therapeutics Average Price by Manufacturers (2019-2024)
2.4 Global Traveler's Diarrhea Therapeutics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Traveler's Diarrhea Therapeutics, Product Type & Application
2.7 Traveler's Diarrhea Therapeutics Market Competitive Situation and Trends
2.7.1 Traveler's Diarrhea Therapeutics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Traveler's Diarrhea Therapeutics Players Market Share by Revenue
2.7.3 Global Traveler's Diarrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Traveler's Diarrhea Therapeutics Retrospective Market Scenario by Region
3.1 Global Traveler's Diarrhea Therapeutics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Traveler's Diarrhea Therapeutics Global Traveler's Diarrhea Therapeutics Sales by Region: 2019-2030
3.2.1 Global Traveler's Diarrhea Therapeutics Sales by Region: 2019-2024
3.2.2 Global Traveler's Diarrhea Therapeutics Sales by Region: 2025-2030
3.3 Global Traveler's Diarrhea Therapeutics Global Traveler's Diarrhea Therapeutics Revenue by Region: 2019-2030
3.3.1 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2019-2024
3.3.2 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2025-2030
3.4 North America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.4.1 North America Traveler's Diarrhea Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Traveler's Diarrhea Therapeutics Sales by Country (2019-2030)
3.4.3 North America Traveler's Diarrhea Therapeutics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.5.1 Europe Traveler's Diarrhea Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Traveler's Diarrhea Therapeutics Sales by Country (2019-2030)
3.5.3 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.6.1 Asia Pacific Traveler's Diarrhea Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Country (2019-2030)
3.6.3 Asia Pacific Traveler's Diarrhea Therapeutics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.7.1 Latin America Traveler's Diarrhea Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Traveler's Diarrhea Therapeutics Sales by Country (2019-2030)
3.7.3 Latin America Traveler's Diarrhea Therapeutics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Traveler's Diarrhea Therapeutics Market Facts & Figures by Country
3.8.1 Middle East and Africa Traveler's Diarrhea Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Traveler's Diarrhea Therapeutics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2019-2030)
4.1.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2019-2024)
4.1.2 Global Traveler's Diarrhea Therapeutics Sales by Type (2025-2030)
4.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2019-2030)
4.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2019-2030)
4.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Type (2019-2024)
4.2.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2025-2030)
4.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2019-2030)
4.3 Global Traveler's Diarrhea Therapeutics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2019-2030)
5.1.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2019-2024)
5.1.2 Global Traveler's Diarrhea Therapeutics Sales by Application (2025-2030)
5.1.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2019-2030)
5.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2019-2030)
5.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Application (2019-2024)
5.2.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2025-2030)
5.2.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2019-2030)
5.3 Global Traveler's Diarrhea Therapeutics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Salix Pharmaceuticals
6.1.1 Salix Pharmaceuticals Corporation Information
6.1.2 Salix Pharmaceuticals Description and Business Overview
6.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolio
6.1.5 Salix Pharmaceuticals Recent Developments/Updates
6.2 P&G
6.2.1 P&G Corporation Information
6.2.2 P&G Description and Business Overview
6.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 P&G Traveler's Diarrhea Therapeutics Product Portfolio
6.2.5 P&G Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Otsuka Pharma
6.4.1 Otsuka Pharma Corporation Information
6.4.2 Otsuka Pharma Description and Business Overview
6.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio
6.4.5 Otsuka Pharma Recent Developments/Updates
6.5 Valneva
6.5.1 Valneva Corporation Information
6.5.2 Valneva Description and Business Overview
6.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Valneva Traveler's Diarrhea Therapeutics Product Portfolio
6.5.5 Valneva Recent Developments/Updates
6.6 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio
6.6.5 Shanghai United Cell Recent Developments/Updates
6.7 PaxVax
6.6.1 PaxVax Corporation Information
6.6.2 PaxVax Description and Business Overview
6.6.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PaxVax Traveler's Diarrhea Therapeutics Product Portfolio
6.7.5 PaxVax Recent Developments/Updates
6.8 Livzon
6.8.1 Livzon Corporation Information
6.8.2 Livzon Description and Business Overview
6.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Livzon Traveler's Diarrhea Therapeutics Product Portfolio
6.8.5 Livzon Recent Developments/Updates
6.9 Immuron
6.9.1 Immuron Corporation Information
6.9.2 Immuron Description and Business Overview
6.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Immuron Traveler's Diarrhea Therapeutics Product Portfolio
6.9.5 Immuron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Traveler's Diarrhea Therapeutics Industry Chain Analysis
7.2 Traveler's Diarrhea Therapeutics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Traveler's Diarrhea Therapeutics Production Mode & Process
7.4 Traveler's Diarrhea Therapeutics Sales and Marketing
7.4.1 Traveler's Diarrhea Therapeutics Sales Channels
7.4.2 Traveler's Diarrhea Therapeutics Distributors
7.5 Traveler's Diarrhea Therapeutics Customers
8 Traveler's Diarrhea Therapeutics Market Dynamics
8.1 Traveler's Diarrhea Therapeutics Industry Trends
8.2 Traveler's Diarrhea Therapeutics Market Drivers
8.3 Traveler's Diarrhea Therapeutics Market Challenges
8.4 Traveler's Diarrhea Therapeutics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
